Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist

By Schroder A.K.   Schopper B.   Al-Hasani S.   Loning M.   Diedrich K.   Ludwig M.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 648-650

Elsevier

Access to resources Recommend Favorite

Lower levels of inhibin A and pro- C during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin

By Nevo O.   Eldar-Geva T.a.   Kol S.   Itskovitz-Eldor J.  

Fertility and Sterility, Vol. 79, Iss. 5, 2003-05 ,pp. : 1123-1128

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma

By Higashijima T.   Kataoka A.   Nishida T.   Yakushiji M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 169-173

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial

By Vercellini P.   Trespidi L.   Zaina B.   Vicentini S.   Stellato G.   Crosignani P.G.  

Fertility and Sterility, Vol. 79, Iss. 6, 2003-06 ,pp. : 1390-1395

Elsevier

Access to resources Recommend Favorite

Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist

By Bo-Abbas Y.Y.   Martin K.A.   Liberman R.F.   Cramer D.W.   Barbieri R.L.  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 694-699

Elsevier

Access to resources Recommend Favorite